Pneuron offers a Distributed Solutions Platform that enables organizations to solve business problems by targeting information at the data source and distributing processing across applications, machines, devices and sensors. The company positions its technology around a new category it calls "Analytics on the Edge," intended to simplify building and managing distributed solution components in IoT and other dispersed environments. Pneuron says its approach is non‑invasive, technology‑agnostic and leverages existing infrastructure to reduce time and cost versus traditional centralized integration projects. Management plans to use the new financing to hire scale‑up resources in sales, sales engineering and implementation to support aggressive projected growth for 2016. The company reports strong historical growth: revenue grew at a CAGR of 173 percent (comparative growth of 639 percent) since its last funding round in March 2013 and it delivered 200 percent revenue and bookings growth in 2014. Pneuron highlights a 2015 Gartner “Cool Vendor” recognition, a global alliance with HP and a new patent for its distributed analytics method. The company emphasizes a stepped investment strategy to minimize dilution for staff and a focus on EBITDA, revenue growth and cash effectiveness. Pneuron’s core product is the Pneuron Platform™, a suite of high-performance “pneurons” that lets enterprises run analytics and applications directly against heterogeneous source systems rather than centralizing data. Its patent-pending approach aims to reduce time and cost of application development by up to 50% and to avoid large data-integration projects. The company is initially focused on complex financial‑services use cases—regulations, risk, conversion management and revenue generation—and is gaining traction in insurance and healthcare through emerging partnerships. Pneuron’s go-to-market includes partnerships with systems integrators and ISVs such as PwC. Management comprises veterans from IBM, PwC, GE, Honeywell, Bunge, Fiserv, CheckFree, the Federal Reserve Bank, Lehman Brothers and Reed Elsevier. The company plans to use new financing to develop industry partnerships, expand into healthcare and other verticals, and hire additional sales and business development representatives.

Total raised

$11M

Funding rounds

2

Latest round

Series B

Latest activity

Jul 2015